Nuclear Medicine and Biology
Volume 33, Issue 1 , Pages 5-13 , January 2006

PET Imaging of the AT1 receptor with [11C]KR31173

  • Tamas G. Zober

      Affiliations

    • Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, MD 21287-0817, USA
    • ,
  • William B. Mathews

      Affiliations

    • Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, MD 21287-0817, USA
    • ,
  • Esen Seckin

      Affiliations

    • Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, MD 21287-0817, USA
    • ,
  • Sung-eun Yoo

      Affiliations

    • The Center for Biological Modulators, The Korea Research Institute of Chemical Technology, Daejeon 305-343, South Korea
    • ,
  • John Hilton

      Affiliations

    • Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, MD 21287-0817, USA
    • ,
  • Jinsong Xia

      Affiliations

    • Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, MD 21287-0817, USA
    • ,
  • Kathryn Sandberg

      Affiliations

    • Department of Medicine, Georgetown University, Washington, DC 20057, USA
    • ,
  • Hayden T. Ravert

      Affiliations

    • Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, MD 21287-0817, USA
    • ,
  • Robert F. Dannals

      Affiliations

    • Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, MD 21287-0817, USA
    • ,
  • Zsolt Szabo

      Affiliations

    • Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, MD 21287-0817, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 410 614 4417; fax: +1 410 614 3896.

Received 12 May 2005 ,Revised 22 August 2005 ,Accepted 23 August 2005.

References 

  1. Kim S, Iwao H. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev. 2000;52:11–34
  2. Goodfriend TL. Angiotensin receptors: history and mysteries. Am J Hypertens. 2000;13:442–449
  3. Hamill TG, Burns HD, Dannals RF, Mathews WB, Musachio JL, Ravert HT, et al. Development of [11C]L-159,884: a radiolabelled, nonpeptide angiotensin II antagonist that is useful for angiotensin II. AT1 receptor imaging. Appl Radiat Isot. 1996;47:211–218
  4. Kim SE, Scheffel U, Szabo Z, Burns HD, Gibson RE, Ravert HT, et al. In vivo labeling of angiotensin II receptors with a carbon-11-labeled selective nonpeptide antagonist. J Nucl Med. 1996;37:307–311
  5. Szabo Z, Kao PF, Burns HD, Gibson RE, Hamill TG, Ravert HT, et al. Investigation of angiotensin II/AT1 receptors with carbon-11-L-159,884: a selective AT1 antagonist. J Nucl Med. 1998;39:1209–1213
  6. Szabo Z, Speth RC, Brown PR, Kerenyi L, Kao PF, Mathews WB, et al. Use of positron emission tomography to study AT1 receptor regulation in vivo. J Am Soc Nephrol. 2001;12:1350–1358
  7. Owonikoko TK, Fabucci ME, Brown PR, Nisar N, Hilton J, Mathews WB, et al. In vivo investigation of estrogen regulation of adrenal and renal angiotensin AT1 receptor expression by PET. J Nucl Med. 2003;45:94–100
  8. Mathews WB, Yoo SE, Lee SH, Scheffel U, Rauseo PA, Zober TG, et al. A novel radioligand for imaging the AT1 angiotensin receptor with PET. Nucl Med Biol. 2004;31:571–574
  9. Hong KW, Kim CD, Lee SH, Yoo SE. The in vitro pharmacological profile of KR31080, a nonpeptide AT1 receptor antagonist. Fund Clin Pharmacol. 1998;12:64–69
  10. Shimoji K, Ravasi L, Schmidt K, Soto-Montenegro ML, Esaki T, Seidel J, et al. Measurement of cerebral glucose metabolic rates in the anesthetized rat by dynamic scanning with 18F-FDG, the ATLAS small animal PET scanner, and arterial blood sampling. J Nucl Med. 2004;45:665–672
  11. Yao R, Seidel J, Johnson CA, Daube-Witherspoon ME, Green MV, Carson RE. Performance characteristics of the 3-D OSEM algorithm in the reconstruction of small animal PET images. Ordered-subsets expectation-maximization. IEEE Trans Med Imaging. 2000;19:798–804
  12. Hilton J, Yokoi F, Dannals RF, Ravert HT, Szabo Z, Wong DF. Column-switching HPLC for the analysis of plasma in PET imaging studies. Nucl Med Biol. 2000;27:627–630
  13. Khurana M, Paliwal JK, Kamboj VP, Gupta RC. Binding of centchroman with human serum as determined by charcoal adsorption method. Int J Pharm. 1999;192:109–114
  14. Yuan JH, Yang DC, Birkmeier J, Stolzenbach J. Determination of protein-binding by in-vitro charcoal adsorption. J Pharmacokinet Biopharm. 1995;23:41–55
  15. Logan J, Fowler JS, Volkow ND, Wolf AP, Dewey SL, Schlyer DJ, et al. Graphical analysis of reversible radioligand binding from time–activity measurements applied to [N-11C-methyl]-(−)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab. 1990;10:740–747
  16. Szabo Z, Vosberg H, Sondhaus CA, Feinendegen LE. Model identification and estimation of organ-function parameters using radioactive tracers and the impulse–response function. Eur J Nucl Med. 1985;11:265–274
  17. Gjedde A, Wong DF, Wagner HN. Transient analysis of irreversible and reversible tracer binding in human brain. In:  Battistin L,  Gerstenbrand F editor. PET and NMR. New perspectives in neuroimaging and in clinical neurochemistry. New York: Alan R. Liss; 1985;p. 223–235
  18. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab. 1983;3:1–7
  19. Vandekerckhove A, Keppens S, De Wulf H. The angiotensin II receptor of rabbit liver: characterization in isolated hepatocytes and effect of GTP. J Endocrinol. 1989;123:131–136
  20. Anversa P, Leri A, Li B, Liu Y, Di Somma S, Kajstura J. Ischemic cardiomyopathy and the cellular renin–angiotensin system. J Heart Lung Transplant. 2000;19:S1–S11
  21. Ohtani S, Fujiwara H, Hasegawa K, Doyama K, Inada T, Tanaka M, et al. Up-regulated expression of angiotensin II type 1 receptor gene in human pathologic hearts. J Card Fail. 1997;3:303–310
  22. Gonzalez A, Lopez B, Ravassa S, Querejeta R, Larman M, Diez J, et al. Stimulation of cardiac apoptosis in essential hypertension: potential role of angiotensin II. Hypertension. 2002;39:75–80
  23. Green LA, Nguyen K, Berenji B, Iyer M, Bauer E, Barrio JR, et al. A tracer kinetic model for 18F-FHBG for quantitating herpes simplex virus type 1 thymidine kinase reporter gene expression in living animals using PET. J Nucl Med. 2004;45:1560–1570
  24. Paradis P, Dali-Youcef N, Paradis FW, Thibault G, Nemer M. Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling. Proc Natl Acad Sci U S A. 2000;97:931–936
  25. Fujimoto Y, Sasaki T, Tsuchida A, Chayama K. Angiotensin II type 1 receptor expression in human pancreatic cancer and growth inhibition by angiotensin II type 1 receptor antagonist. FEBS Lett. 2001;495:197–200
  26. Maluccio M, Sharma V, Lagman M, Konijn G, Suthanthiran M. Angiotensin II receptor blockade: a novel strategy to prevent immunosuppressant-associated cancer progression. Transplant Proc. 2001;33:1820–1821
  27. Smith GR, Missailidis S. Cancer, inflammation and the AT1 and AT2 receptors. J Inflam (Lond). 2004;1:3
  28. Masuko H, Jin MB, Horiuchi H, Suzuki T, Taniguchi M, Shimamura T, et al. Protective effect of angiotensin II type I receptor antagonist, CV-11974, on ischemia and reperfusion injury of the liver. Transplantation. 2001;71:1034–1039
  29. Wu Z, Maric C, Roesch D, Zheng W, Verbalis JG, Sandberg K. Estrogen regulates adrenal angiotensin type 1 receptors by modulating AT1 receptor translation. Endocrinology. 2003;144:3251–3261
  30. Aguilera G. Role of angiotensin II receptor subtypes on the regulation of aldosterone secretion in the adrenal glomerulosa zone in the rat. Mol Cell Endocrinol. 1992;90:53–60
  31. Giacchetti G, Opocher G, Sarzani R, Rappelli A, Mantero F. Angiotensin II and the adrenal. Clin Exp Pharmacol Physiol Suppl. 1996;3:S119–S124
  32. McCaa RE. Role of the renin–angiotensin system in the regulation of aldosterone biosynthesis and arterial pressure during sodium deficiency. Circ Res. 1977;40:I157–I162
  33. Tanabe A, Naruse M, Arai K, Naruse K, Yoshimoto T, Seki T, et al. Gene expression and roles of angiotensin II type 1 and type 2 receptors in human adrenals. Horm Metab Res. 1998;30:490–495
  34. Schubert B, Fassnacht M, Beuschlein F, Zenkert S, Allolio B, Reincke M. Angiotensin II type 1 receptor and ACTH receptor expression in human adrenocortical neoplasms. Clin Endocrinol (Oxf). 2001;54:627–632

PII: S0969-8051(05)00206-4

doi: 10.1016/j.nucmedbio.2005.08.005

Nuclear Medicine and Biology
Volume 33, Issue 1 , Pages 5-13 , January 2006

Article Tools

* Image Usage & Resolution